Dexcom
Sophia Lauwers is a highly skilled regulatory affairs professional with extensive experience in the medical device industry. Currently serving as a Staff Regulatory Affairs Specialist at Dexcom since 2022, Sophia focuses on the software and cybersecurity aspects of continuous glucose monitoring systems. Prior roles include Regulatory Affairs Associate III at Hologic, Inc., where leadership in PMA and De Novo submissions took place, and positions at Fresenius Medical Care North America, VRC Metal Systems, and UDRI that involved regulatory documentation, business development, and engineering support for advanced technologies. Sophia holds multiple graduate degrees in Chemical Engineering and Material Science from Worcester Polytechnic Institute and the University of Dayton.
This person is not in any teams
This person is not in any offices
Dexcom
45 followers
Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. The company is the leader in transforming diabetes care and management by providing CGM technology to help patients and healthcare professionals better manage diabetes.